CL
CLB
Core Laboratories Inc. /DE/
$13.75
+0.22%
$632.4M
No data for this timeframe.
Vol
Market Cap$632.4M
Cap SizeSmall Cap
Inst. Holders8 funds
Inst. Value$296.8M
Inst. Activity2 buys / 2 sells
Recent Activity
May 1, 2026
Insider
Tattoli Mark Damian sold 250 shares
SVP, Gen Counsel & Secretary @ $0.00 ($0.00)
May 1, 2026
Insider
Tattoli Mark Damian sold 250 shares
SVP, Gen Counsel & Secretary @ $0.00 ($0.00)
May 1, 2026
Insider
Tattoli Mark Damian sold 97 shares
SVP, Gen Counsel & Secretary @ $14.07 ($1.4K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
183,400 shares ($2.9M)
Inst.
BANK OF AMERICA CORP — TRIM
140,700 shares ($2.3M)
Apr 30, 2026
short_volume
Short Volume: CLB — 62.3% short (0.3M / 0.5M)
Short: 322,811 | Exempt: 4,983 | TRF Vol: 518,216 | Short Ratio: 62.3% | Off-exchange volume (dark p
Price Targets
Historical data — last covering-analyst action Jul 2025. No current recommendation available.
$16.33 (Jul 2025)
Current $13.75
Low $12.00
Median $15.00
High $22.00
3 analysts
$12.00
$22.00
Analyst Ratings
0Strong Buy
1Buy
3Hold
5Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 16, 2025 | Stifel | MAINTAIN | Hold → Hold |
| May 13, 2025 | Citigroup | MAINTAIN | Neutral → Neutral |
| Apr 15, 2025 | Stifel | MAINTAIN | Hold → Hold |
| Mar 12, 2025 | Citigroup | UPGRADE | Sell → Neutral |
| Feb 20, 2025 | Citigroup | MAINTAIN | Sell → Sell |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.09 | $0.09 — $0.09 | -53% YoY | 1 |
| Next Q | $0.18 ▼ -10.0% | $0.18 — $0.18 | -18% YoY | 1 |
| Current FY | $0.54 ▼ -5.3% | $0.54 — $0.54 | -28% YoY | 1 |
| Next FY | $0.85 ▼ -1.2% | $0.81 — $0.90 | 58% YoY | 2 |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ARIEL INVESTMENTS, LLC | $219.0M | ADD |
| VANGUARD GROUP INC | $49.4M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $11.8M | NEW |
| MORGAN STANLEY | $7.8M | TRIM |
| WELLS FARGO & COMPANY/MN | $3.5M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 1, 2026 | Tattoli Mark | M | $0.00 |
| May 1, 2026 | Tattoli Mark | M | $0.00 |
| May 1, 2026 | Tattoli Mark | F | $1.4K |
| Apr 1, 2026 | Murray Katherine | M | $0.00 |
| Apr 1, 2026 | Murray Katherine | A | $0.00 |
8 institutional holders with $296.8M total value (18,514,044 shares) as of 2025-Q4. Top holders: ARIEL, VANGUARD, CHARLES.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ARIEL INVESTMENTS, LLC | 13,661,000 | $219.0M | 73.8% | ADD +25.5% |
| 2 | VANGUARD GROUP INC | 3,079,882 | $49.4M | 16.6% | TRIM -32.0% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 737,550 | $11.8M | 4.0% | NEW |
| 4 | MORGAN STANLEY | 485,038 | $7.8M | 2.6% | TRIM -34.1% |
| 5 | WELLS FARGO & COMPANY/MN | 218,773 | $3.5M | 1.2% | — |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 183,400 | $2.9M | 1.0% | DOUBLED +436.6% |
| 7 | BANK OF AMERICA CORP /DE/ | 140,700 | $2.3M | 0.8% | TRIM -59.0% |
| 8 | FMR LLC | 7,701 | $123.4K | 0.0% | ADD +83.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 34,181 | 183,400 | +436.6% | $2.9M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 343,340 | 140,700 | -59.0% | $2.3M | 2025-Q4 |
| FMR LLC | ADD | 4,204 | 7,701 | +83.2% | $123.4K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 30,551 | 0 | -100.0% | $0.00 | 2025-Q4 |
| VANGUARD GROUP INC | TRIM | 4,479,090 | 3,047,390 | -32.0% | $37.7M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 231,813 | 343,340 | +48.1% | $4.2M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 34,181 | — | $422.5K | 2025-Q3 |
| FMR LLC | ADD | 2,745 | 4,204 | +53.2% | $52.0K | 2025-Q3 |
| ARIEL INVESTMENTS, LLC | ADD | 10,342,025 | 12,976,463 | +25.5% | $149.5M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 168,432 | 231,813 | +37.6% | $2.7M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 52,160 | 25,391 | -51.3% | $292.5K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 894,772 | 589,579 | -34.1% | $8.8M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 84,277 | 52,160 | -38.1% | $781.9K | 2025-Q1 |
| FMR LLC | NEAR_EXIT | 16,187 | 3,449 | -78.7% | $51.7K | 2025-Q1 |
| NORGES BANK | EXIT | 110,328 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 27,204 | 377,092 | +1286.2% | $6.5M | 2024-Q4 |
| NORGES BANK | TRIM | 165,424 | 110,328 | -33.3% | $1.9M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 27,600 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 529,522 | — | $9.8M | 2024-Q3 |
11 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 1, 2026 | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | 250 | $0.00 | $0.00 |
| May 1, 2026 | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | M | 250 | $0.00 | $0.00 |
| May 1, 2026 | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | F | 97 | $14.07 | $1.4K |
| Apr 1, 2026 | Murray Katherine | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Murray Katherine | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | Murray Katherine | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | ANASTASIO CURT | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | ANASTASIO CURT | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | Klingensmith Harvey Robert | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Klingensmith Harvey Robert | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | ANASTASIO CURT | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Temeng Kwaku | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | MARTINOVICH ROBERT F | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Klingensmith Harvey Robert | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Temeng Kwaku | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | Temeng Kwaku | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | MARTINOVICH ROBERT F | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | MARTINOVICH ROBERT F | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Carnes Martha Z. | Director | M | 8,069 | $0.00 | $0.00 |
| Apr 1, 2026 | Carnes Martha Z. | Director | A | 7,895 | $0.00 | $0.00 |
| Apr 1, 2026 | Carnes Martha Z. | Director | M | 8,069 | $0.00 | $0.00 |
| Feb 12, 2026 | Bruno Lawrence | Chairman and CEO | A | 204,340 | $0.00 | $0.00 |
| Feb 12, 2026 | Hill Christopher Scott | SVP & CFO | A | 70,008 | $0.00 | $0.00 |
| Feb 12, 2026 | Teo Sow Hang | CAO & Treasurer | A | 7,526 | $0.00 | $0.00 |
| Feb 12, 2026 | Tattoli Mark Damian | SVP, Gen Counsel & Secretary | A | 33,490 | $0.00 | $0.00 |
| Feb 12, 2026 | Gresham Gwendolyn | SVP | A | 33,490 | $0.00 | $0.00 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jul 2025): 10% buy across 10 analysts — 0 strong buy, 1 buy, 3 hold, 5 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jul 2025. No current recommendation available.
$16.33 mean target (Jul 2025)
$12.00 Low
$22.00 High
| Metric | Value |
|---|---|
| Current Price | $13.75 |
| Target Low | $12.00 |
| Target Mean | $16.33 |
| Target Median | $15.00 |
| Target High | $22.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.09 | $0.09 | $0.09 | -52.6% | +0.0% | 1↑ 1↓ | $0.1B | -2.4% | 1 |
| Next Q 2026-09-30 |
$0.18 | $0.18 | $0.18 | -18.2% | -10.0% | 0↑ 2↓ | $0.1B | 0.4% | 1 |
| Current FY 2026-12-31 |
$0.54 | $0.54 | $0.54 | -28.0% | -5.3% | 1↑ 1↓ | $0.5B | -1.1% | 1 |
| Next FY 2027-12-31 |
$0.85 | $0.81 | $0.90 | 58.3% | -1.2% | 0↑ 1↓ | $0.5B | 5.2% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.090 | |
| 7d ago | $0.090 | |
| 30d ago | $0.090 | |
| 60d ago | $0.185 | -0.095 |
| 90d ago | $0.185 | -0.095 |
2 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jul 16, 2025 | Stifel | MAINTAIN | Hold | Hold |
| May 13, 2025 | Citigroup | MAINTAIN | Neutral | Neutral |
| Apr 15, 2025 | Stifel | MAINTAIN | Hold | Hold |
| Mar 12, 2025 | Citigroup | UPGRADE | Sell | Neutral |
| Feb 20, 2025 | Citigroup | MAINTAIN | Sell | Sell |
| Oct 31, 2024 | Citigroup | MAINTAIN | Sell | Sell |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 0 | 1 | 3 | 5 | 1 | 10% | |
| Apr 1, 2026 | 0 | 1 | 3 | 5 | 1 | 10% | |
| Mar 1, 2026 | 0 | 1 | 3 | 5 | 1 | 10% | |
| Feb 1, 2026 | 0 | 1 | 3 | 5 | 1 | 10% | |
| Jan 1, 2026 | 0 | 1 | 3 | 5 | 1 | 10% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 30, 2026
short_volume
Short Volume: CLB — 62.3% short (0.3M / 0.5M)
Short: 322,811 | Exempt: 4,983 | TRF Vol: 518,216 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
earnings_calendar
CLB Q1 2026 Earnings After Market Close — 2026-04-29
Feb 6, 2026
short_interest
FTD: CLB — 37,011 shares ($0.7M) failed to deliver
Settlement: 20260206, Price: $18.78, FTD Value: $695,066.58, CORE LABORATORIES INC COM (DE)